Scientists have discovered why some cells with doubled DNA content resist normal death pathways, offering clues about cancer development and aging processes linked to genomic instability.
Researchers identified molecular switches that allow polyploid cells to survive despite carrying abnormal genetic material that typically triggers elimination mechanisms. The work sheds light on how such cells contribute to tumor progression and tissue dysfunction over time.
Using live-cell imaging and CRISPR screening, the team mapped proteins that override apoptosis signals in DNA-doubled populations. These cells arise through failed division or stress responses and accumulate in certain precancerous lesions.
Understanding survival pathways may enable therapies that force vulnerable polyploid cells to complete programmed death, potentially slowing malignant transformation. Aging tissues also harbor polyploid cells that may impair organ function through secreted inflammatory factors.
The findings were published in a peer-reviewed journal with commentary noting implications for chemotherapy resistance, because some treatments inadvertently promote polyploid states. Pharmaceutical researchers are evaluating whether targeting identified pathways enhances existing oncology regimens.
Clinical translation remains early, but the discovery adds mechanistic detail to long-standing observations linking whole-genome duplication with disease.
Oncology researchers said targeting polyploid survival mechanisms may complement existing DNA-damage therapies that currently eliminate only a fraction of abnormally doubled tumor cells.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/top/health/